Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2016.516 | Replication Kinetics of Different Norovirus Genotypes and Haplotypes in Stem Cell-derived Human Intestinal Enteroid Culture |
Dr. CHAN Martin Chi Wai 陳子蔚 |
| 2015.110 | A 40-year-old question – what is the functional receptor for human norovirus? |
Dr. CHAN Martin Chi Wai 陳子蔚 |
| 2016.167 | Virus Genotype Distribution of Local Hepatitis E Virus Infection |
Dr. CHAN Martin Chi Wai 陳子蔚 |
| 2016.170 | Global Distribution of the Emergent Norovirus Genogroup II Genotype 17 Kawasaki 2014 Variant |
Dr. CHAN Martin Chi Wai 陳子蔚 |
| 2015.268 | Clinical and Virological Characterization of the Novel Norovirus GII.17 Hong Kong 2014 |
Dr. CHAN Martin Chi Wai 陳子蔚 |
| 2017.216 | Use of Next-generation Sequencing to Identify New Intestinal Viruses Associated with Unexplained Acute Gastroenteritis |
Dr. CHAN Martin Chi Wai 陳子蔚 |
| 2016.445 | Evaluation of an Early Alert and Research Platform for Seasonal and Atypical Local Norovirus Activity (Noro-EAR) via Rapid Sequence-based Genomic Molecular Typing |
Dr. CHAN Martin Chi Wai 陳子蔚 |
| 2016.052 | Host interactome of human norovirus structural proteins |
Dr. CHAN Martin Chi Wai 陳子蔚 |
| 2017.130 | Genome-wide CRISPR screen for host factors associated with norovirus infections in stem cell-derived human intestinal enteroid model |
Dr. CHAN Martin Chi Wai 陳子蔚 |
| 2017.088 | Characteristics and Clinical Relevance of Microbiome Changes in Severe Influenza and Respiratory Syncytial Virus Infection |
Dr. CHAN Martin Chi Wai 陳子蔚 |
| 2015.558 | Role of host genetic factors in hospitalized norovirus gastroenteritis |
Dr. CHAN Martin Chi Wai 陳子蔚 |
| 2014.141 | Genetic Susceptibility of Hong Kong Ethnic Chinese to Severe Influenza and RSV Infections | Dr. CHAN Martin Chi Wai |
| 2014.115 | Laboratory study of binding characteristics of native norovirus and synthetic norovirus-like particles | Dr. CHAN Martin Chi Wai |
| 2020.346 | Prevalence and Monitoring of Psychiatric Out-patients Taking High-Dose Antipsychotic therapy (HDAT) in Hong Kong | Ms. CHAN Mandy Man Ting |
| 2020.048 | The effectiveness of Crew Resource Management based Simulation Training (CRM-ST) program in improving student midwives’ performance in management of primary postpartum haemorrhage: a randomized controlled trial |
Dr CHAN Man Yi 陳敏兒 |
| 2013.328 | A pilot study on effectiveness of self-efficacy based educational programme on maternal breastfeeding self-efficacy and breastfeeding duration: A longitudinal, randomized controlled study. | Ms Chan Man Yi |
| 2020.580 | Effect of foot orthotic intervention on postural stability of elderly -a pilot study | Mr. CHAN Man Lung |
| 2005.191 | Psychiatric Morbidity and Health-Related Quality of Life in Parkinson's Disease | CHAN Man Lui |
| 2011.436 | Uptake rate and determinants for influenza vaccination in a local general out-patient clinic in Hong Kong | Dr Chan Man Hung |
| 2024.039 | Stereotactic Body Radiotherapy (SBRT) in Advanced Hepatocellular Carcinoma with Oligoprogression on Atezolizumab plus Bevacizumab | Dr. CHAN Long |
| 2013.015 | Are Hong Kong Construction Workers physically fit to perform jobs? A Cross-sectional study | Mr Chan Lok Hang |
| 2012.176 | The effect of Telbivudine on renal function and proteinuria in patients with chronic hepatitis B infection and chronic kidney diseases | Prof. Chan Lik-Yuen Henry |
| 2010.599 | A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ORAL PF-04136309 500MG BID IN SUBJECTS WITH CHRONIC HCV INFECTION AND RAISED AMINOTRANSFERASES | Prof Chan Lik-yuen Henry |
| 2010.498 | Dose-Ranging Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Pegylated Interferon Lambda (BMS-914143) Monotherapy in Interferon-Naive Patients with Chronic Hepatitis B Virus Infection who are HBeAg-positive | Prof CHAN Lik Yuen, Henry |
| 2009.161 | A Study on the Sustainability of Response to Anti-Viral Agents in Chronic Hepatitis B | Prof Chan Lik Yuen, Henry |
| 2008.367 | Development of a Non-Invasive Algorithm for Advanced Liver Fibrosis in Chronic Hepatitis B | Prof. Chan Lik Yuen, Henry |
| 2011.429 | Alcohol Related Liver Damage in Hong Kong | Prof. Chan Lik Yuen, Henry |
| 2010.286 | Efficacy of entecavir or tenofovir in chronic hepatitis B patients with lamivudine resistance suboptimal virological response to adefovir | Prof Chan Lik Yuen, Henry |
| 2011.135 | Establishment of Specimen Bank for Hepatology Research | Prof Chan Lik Yuen Henry |
| 2013.115 | An Open Label, Phase 2a, Single-Arm Study of the Antifibrotic Activity of FG-3019 in Subjects with Advanced Liver Fibrosis due to Chronic Hepatitis C Infection (HCV) | Prof Chan Lik Yuen Henry |
| 2012.046 | Serum hepatitis B surface antigen levels to guide the stopping of entecavir in HBeAg-negative chronic hepatitis B | Prof Chan Lik Yuen Henry |
| 2012.536 | A multicenter open-label study to evaluate the safety and efficacy of PEG-Intron™ versus PEGASYS™ in subjects with HBeAg positive chronic hepatitis B and HBeAg negative chronic hepatitis B | Prof. Chan Lik Yuen Henry |
| 2017.177 | A Phase 3, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Switching from Tenofovir Disoproxil Fumarate (TDF) 300 mg QD to Tenofovir Alafenamide (TAF) 25mg QD in Subjects with Chronic Hepatitis B who are Virologically Suppressed |
Dr. CHAN Lik Yuen 陳力元 |
| 2015.124 | A MULTIPLE-CENTER, RANDOMIZED, PARTIALLY DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, PHARMACODYNAMICS AND ANTIVIRAL EFFECTS OF 12-WEEK TREATMENT WITH RO6864018 IN VIROLOGICALLY SUPPRESSED PATIENTS WITH CHRONIC HEPATITIS B VIRUS INFECTION |
Prof. CHAN Lik Yuen 陳力元 |
| 2016.089 | A MULTIPLE-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-ASCENDING DOSE AND MULTIPLE-ASCENDING DOSE, ADAPTIVE PARALLEL STUDY TO INVESTIGATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF RO7020322 FOLLOWING ORAL ADMINISTRATION IN HEALTHY SUBJECTS AND CHRONIC HEPATITIS B PATIENTS |
Dr. CHAN Lik Yuen 陳力元 |
| 2017.328 | A PHASE I, SPONSOR-OPEN, INVESTIGATOR-BLINDED, SUBJECT-BLINDED, MULTI-CENTER, PLACEBO-CONTROLLED STUDY TO EVALUATE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF ORAL ADMINISTRATION OF RO7020531: (1). SINGLE AND MULTIPLE ASCENDING DOSES IN HEALTHY MALE AND FEMALE SUBJECTS; (2). 6-WEEK TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS B VIRUS INFECTION |
Prof. CHAN Lik Yuen 陳力元 |
| 2013.138 | Orphan nuclear receptor estrogen-related receptor alpha (ERRa): functional roles and potential therapeutic targeting in hormone-dependent and -independent prostate and breast cancers | Professor Chan Leung Franky |
| 2010.579 | Functional roles of an orphan nuclear receptor Tailless TLX in advanced prostate cancer | Prof CHAN Leung Franky |
| 2008.168 | A Functional Study of An Epithelial-Mesenchymal Transition Regulatory Transcription Factor Snail in Prostate Cancer | Prof. Chan Leung Franky |
| 2014.626 | Evaluation of the psychometric properties of the Chinese version of the Multidimensional Fatigue Inventory among community dwelling older adults with multicomorbidities by a non-experimental, prospective, descriptive, correlation study design | Mr Chan Leong Tat |
| 2015.512 | Effect of a structured aerobic exercise programme in managing fatigue among community dwelling older adults with multicomorbidities by a prospective randomized controlled trial |
Mr. CHAN Leong Tat 陳亮達 |
| 2014.410 | End-of-life decisions in Neonatal Intensive Care Unit: A Retrospective Analysis of Modes of Deaths in the NICU | Dr CHAN Lawrence Chi Ngong |
| 2019.175 | Variation in intensive care practices for moderate to severe traumatic brain injury |
Dr. CHAN Lawrence Chi Ngong 陳子昂 |
| 2017.533 | Prevalence of neuromyelitis optica in Hong Kong |
Dr. CHAN Larry Wai Lun 陳偉麟 |
| 2024.326 | Impact of Radiotherapy on the Dynamic Changes of Circulating Cell-free DNA in Patients with Hepatocellular Carcinoma | Dr. CHAN Landon |
| 2024.311 | Stereotactic Body Radiotherapy with Immunotherapy (Atezolizumab plus Bevacizumab) in Patients with Advanced HCC and Major Portal Vein Tumour Thrombosis | Dr. Chan Landon |
| 2010.563 | An open-label, randomized, multi-center, phase II study to compare the safety and efficacy of TKI258 versus sorafenib as first-line treatment in adult patients with advanced hepatocellular carcinoma | Assistant Professor Chan Lam, Stephen |
| 2011.145 | The use of circulating methylated RASSF1A in prognostication and monitoring of treatment response for inoperable hepatocellular carcinoma | Dr. Chan Lam, Stephen |
| 2024.253 | A Phase 1b Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMG 193 in Combination With other Therapies in Subjects With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous MTAP-deletion – Master Protocol | Professor CHAN Lam Stephen |
| 2010.564 | A Randomized Phase III study of Oxaliplatin (Eloxatin) and Capecitabine on top of Sorafenib versus Sorafenib alone as first-line palliative treatment in advanced hepatocellular carcinoma patients ineligible for curative resection or local treatment | Prof Chan Lam |
Page 202 of 262.